Brief: Adial Pharmaceuticals Announces Peer-Reviewed Publication Highlighting clinical Results Of AD04 As A Potential Treatment For Alcohol Use Disorder
April 10 (Reuters) - Adial Pharmaceuticals Inc ADIL.O :
* ADIAL PHARMACEUTICALS ANNOUNCES PEER-REVIEWED PUBLICATION
HIGHLIGHTING PROMISING SAFETY DATA AND HIGH PATIENT COMPLIANCE
IN A CLINICAL TRIAL OF AD04 AS A POTENTIAL TREATMENT FOR
ALCOHOL USE DISORDER
Source text for Eikon: ID:nGNX9qFBhr
Further company coverage: ADIL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Adial Pharmaceuticals
See all newsBrief: Adial Pharmaceuticals Announces Name Change To Azora Therapeutics
Brief: Adial Pharmaceuticals Announces Planned Appointment Of Celia Economides As Chief Financial Officer
Brief: Adial Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Brief: Adial Pharmaceuticals - Proposed Resale Of Up To 25,148,970 Shares Of Common Stock By Selling Stockholders - SEC Filing
Brief: Adial Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)